ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SNG Synairgen Plc

4.52
-0.235 (-4.94%)
24 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.235 -4.94% 4.52 4.35 4.69 4.75 4.36 4.75 212,429 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.50 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.50.

Synairgen Share Discussion Threads

Showing 5726 to 5750 of 99175 messages
Chat Pages: Latest  235  234  233  232  231  230  229  228  227  226  225  224  Older
DateSubjectAuthorDiscuss
30/4/2020
13:07
How so?

To sell at 69p and then buy back straight away at 64p

Its called smart dealing:))

chinadog3
30 Apr '20 - 12:58 - 5661 of 5667
0 4 0
BMNSA congrats but really no offence but who cares other than you. I suggest that enlightened LTHs will do rather better

whites123
30 Apr '20 - 13:02 - 5666 of 5667
0 0 0
BMNSA.

Well done.....
I guess you are off now?
LTH, or those holding for the real news will make any profits you have banked pale into insignificance..

It always makes me laugh when people get into a good thing... They then close out and say "Get into XYZ, I foresee a 50% increase etc" whereas the reality is the one they had just sold out of will produce a 500% increase... :-)

bmnsa
30/4/2020
13:06
Nobster/ Lit Het

My guess is that RM is managing expectations wrt a June reveal.

Only centres on the trial list can recruit and the the rigorous participant screen is the reason for only 75 signed up (presumably) as of yesterday.

Dosing started 4 weeks ago so allowing for the reduction in hospital admissions the balance should be on the trial within two weeks - let's say last one recruits on May 12th.

then to the end of the month for dosing and evaluation.

Trial complete by end of May results the same day.

toffeeman
30/4/2020
13:04
Christ its only 6 weeks at a guess and has nothing at all to do with the retrace , thats just trading
d1nga
30/4/2020
13:02
All great news...except "June" .
This could take off again at any time with,hopefully,worldwide media coverage.

For me "home trials" is huge news.Still a huge company in the making for those that wait.

lithological heterogeneities
30/4/2020
13:02
BMNSA.

Well done.....
I guess you are off now?
LTH, or those holding for the real news will make any profits you have banked pale into insignificance..

It always makes me laugh when people get into a good thing... They then close out and say "Get into XYZ, I foresee a 50% increase etc" whereas the reality is the one they had just sold out of will produce a 500% increase... :-)

whites123
30/4/2020
13:01
Coming back down to top up territory. I sold out of GDR at the highs yesterday so plenty more left to throw in here. A great rise on great news.
dovey21
30/4/2020
13:01
al least finncap arent overegging the pudding

but on successful trial I'd expect A LOT MORE than 240p

d1nga
30/4/2020
13:00
FinCapp news!


Target £1.20, with possible £2.40 on positive outcome

makendon
30/4/2020
12:58
I said.... Be patient... (Its a shame the style has gone).
That things are extremely positive.
Even a short term view (Months) will likely pay huge dividends..
Take small profits if you really wish to, but there is a bigger picture here..
Read what you have been told today and absorb.

whites123
30/4/2020
12:58
BMNSA congrats but really no offence but who cares other than you. I suggest that enlightened LTHs will do rather better
chinadog3
30/4/2020
12:57
Sweaty finger time, so annoying.
slinkyj
30/4/2020
12:55
Just nipped a nice 69p sale in before the drop.
Better than s.x :))

bmnsa
30/4/2020
12:53
Top ups over the last week or so are paying dividends! Well done to the holders. :-)
dovey21
30/4/2020
12:52
Wait until the press get hold of this news for the real wow!
rafboy
30/4/2020
12:52
Well done everyone who held on to the shares despite the testing past few weeks. Hopefully we smash through the glass ceiling today or tomorrow.
adman50
30/4/2020
12:51
I cannot believe it. Tern yesterday/Today and SNG today. I loaded up on both and have sold some of them to get balance and take some money off the table.
vitec
30/4/2020
12:50
likya did ok he lunped into tern which had a massive spike
d1nga
30/4/2020
12:49
Wonder how the Chinese were able to show such +ve results for inhaled interferon so relatively easily early on in Wuhan?
wetdream
30/4/2020
12:47
Repeat after me, DO NOT SELL, DO NOT SELL !!
mostro
30/4/2020
12:46
Hope Likya is enjoying proceeds off his 50p sales from yesterday lol!
blueblood
30/4/2020
12:45
VitecFair to say you have had a couple of good days. ; )
cambradjones
30/4/2020
12:45
Southampton, UK - 30 April 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it has received approvals to extend the SG016 trial to patients with SARS-CoV-2 in the home environment.

The objective is to initiate dosing with SNG001 (or placebo) earlier in the infection cycle, and before severe lower respiratory tract symptoms have developed. In due course, details of the design, implementation and timing of this novel study will be disclosed more fully.

The treatment of patients in the hospital setting in the SG016 study is progressing well, with more than 75 patients out of the target 100 now dosed with Synairgen's wholly-owned drug SNG001 or placebo. Results from this part of the study are still expected in June 2020.

bmnsa
30/4/2020
12:45
Think they will enroll them quicker now that they can get the test result quicker.
fidra
30/4/2020
12:44
i'm quite surprised they still need another 25 patient tbh , thats why the June date for completion I guess
d1nga
30/4/2020
12:43
Catch it quick before hospitilisation. Fabulous move
chinadog3
Chat Pages: Latest  235  234  233  232  231  230  229  228  227  226  225  224  Older

Your Recent History

Delayed Upgrade Clock